Sabhir Madhi, MD

Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, South Africa

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-100) Durable immune response induced by self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidates against variants of concern (VOC) in HIV-negative and people living with HIV (PLWH) populations in South Africa, irrespective of prior SARS-CoV-2 vaccination
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT